ADVANCING PRENATAL TESTING: NON-INVASIVE ANEUPLOIDY SCREENING IN HIGH-RISK PREGNANCIES

Authors

  • Surraya Israr
  • Hina Akhtar
  • Zainab Asghar
  • Muhammad Ahmad Albajuri
  • Iffat Jabeen
  • Mukhzarah Nasr Chaudhry

DOI:

https://doi.org/10.53555/qvnay652

Keywords:

Trisomy 21, high-risk pregnancy, fetal aneuploidy, non-invasive prenatal testing, and prenatal screening.

Abstract

Non-invasive prenatal testing (NIPT) has further advanced the idea of prenatal screening through the accurate identification of fetal aneuploidies. It is most effective for women who are considered to be at high-risk pregnancies to eliminate the use of invasive procedures.

Objectives:  This study assesses the efficiency of the NIPT technology in the identification of trisomy 21, 18, and 13 in high-risk pregnancies concerning the sensitivity, specificity, and positive predictive value.

Materials and Methods:  The current study was a hospital-based prospective study conducted at Department of Obstetrics and Gynaecology, Sir Ganga Ram Hospital / Fatima Jinnah Medical University Lahore, Pakistan from January 2024 to June 2024. Two hundred fifty high-risk pregnant women only got NIPT done and diagnostic tests among the positive ones. Sensitivity, specificity, and predictive values were analyzed.

Results:  In terms of efficiency NIPT has high sensitivity since it disclosed 100% of trisomy 21, 88.9% of trisomy 18, and 50% of trisomy 13 while the specificity was 97.8%. Limitations of this research indicated that there were false positive cases that should undergo further testing.

Conclusion:  NIPT can be helpful in high-risk pregnancies. It helps in the elimination of invasive procedures while improving the accuracy of detection of aneuploidies.

Author Biographies

  • Surraya Israr

    Associate Professor, Department of Gyne Obs, GKMC /BKMC Swabi KPK, Pakistan

  • Hina Akhtar

    Assistant Professor, Department of Obstetrics and Gynaecology, Sir Ganga Ram Hospital / Fatima Jinnah Medical University Lahore, Pakistan

  • Zainab Asghar

    Consultant Gynaecologist, THQ Hospital Pindibhattian, Pakistan

  • Muhammad Ahmad Albajuri

    enior Registrar, Department of Obstetrics and Gynecology, Neom hospital / Saudi Arabia

  • Iffat Jabeen

    Senior Registrar, Gynae Unit 2, Jinnah Hospital Lahore, Pakistan

  • Mukhzarah Nasr Chaudhry

    Senior Registrar, Chaudhry Muhammad Akram Teaching and Research Hospital,Azra Naheed Medical College, Lahore, Pakistan

References

- Merriel, A., Alberry, M. and Abdel-Fattah, S., 2021. Implications of non-invasive prenatal testing for identifying and managing high-risk pregnancies. European Journal of Obstetrics & Gynecology and Reproductive Biology, 256, pp.32-39.

2- Chen, Y., Yang, F., Shang, X., Liu, S., Li, M. and Zhong, M., 2022. A study on non-invasive prenatal screening for the detection of aneuploidy. Ginekologia Polska, 93(9), pp.716-720.

3- Zhu, H., Jin, X., Xu, Y., Zhang, W., Liu, X., Jin, J., Qian, Y. and Dong, M., 2021. Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age. BMC Pregnancy and Childbirth, 21, pp.1-6.

4- del Arco de la Paz, A., Giménez-Rodríguez, C., Selntigia, A., Meseguer, M. and Galliano, D., 2024. Advancements and Challenges in Preimplantation Genetic Testing for Aneuploidies: In the Pathway to Non-Invasive Techniques. Genes, 15(12), p.1613.

5- Giovannopoulou, E., Tsakiridis, I., Mamopoulos, A., Kalogiannidis, I., Papoulidis, I., Athanasiadis, A. and Dagklis, T., 2022. Invasive prenatal diagnostic testing for aneuploidies in singleton pregnancies: a comparative review of major guidelines. Medicina, 58(10), p.1472.

6- Baranova, E.E., Sagaydak, O.V., Galaktionova, A.M., Kuznetsova, E.S., Kaplanova, M.T., Makarova, M.V., Belenikin, M.S., Olenev, A.S. and Songolova, E.N., 2022. Whole genome non-invasive prenatal testing in prenatal screening algorithm: Clinical experience from 12,700 pregnancies. BMC Pregnancy and Childbirth, 22(1), p.633.

7- Pires, L.M.L.M., 2022. Non-Invasive Prenatal Screening for Common Aneuploidies-Implementation, Consolidation and Future (Master's thesis, Universidade de Coimbra (Portugal)).

8- Zhang, Y., Xu, H., Zhang, W. and Liu, K., 2022. Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases. Frontiers in Genetics, 13, p.864076.

9- Zhu, X., Chen, M., Wang, H., Guo, Y., Chau, M.H.K., Yan, H., Cao, Y., Kwok, Y.K.Y., Chen, J., Hui, A.S.Y. and Zhang, R., 2021. Clinical utility of expanded non‐invasive prenatal screening and chromosomal microarray analysis in high‐risk pregnancy. Ultrasound in Obstetrics & Gynecology, 57(3), pp.459-465.

10- Soukkhaphone, B., Lindsay, C., Langlois, S., Little, J., Rousseau, F. and Reinharz, D., 2021. Non‐invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta‐analysis of diagnostic test accuracy studies. Molecular Genetics & Genomic Medicine, 9(5), p.e1654.

11- Su, J.Y., Wei, Y.N., Chen, H.F., Tong, J.R., Chen, Y., Deng, L., Huang, L.L. and Zhang, L.Y., 2023. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age. European Review for Medical & Pharmacological Sciences, 27(15).

12- Zhao, Y., Xue, Z., Geng, Y., Zhu, J., Hu, M. and Jiang, M., 2023. Understanding knowledge, perception, and willingness of non-invasive prenatal testing for fetal aneuploidy: a survey among Chinese high-risk pregnant women. Frontiers in Medicine, 10, p.1232942.

13- Xu, C., Cai, X., Chen, S., Luo, Q., Xi, H., Zhang, D., Wang, H., Wu, Y., Huang, H.F. and Zhang, J., 2021. Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study. BMJ open, 11(8), p.e053617.

14- Sun, Q., Xu, J., Yao, Y., Huang, X., Zhao, D., Lu, S., Yao, B. and Chen, L., 2024. Efficacy of non-invasive chromosome screening, preimplantation genetic testing for aneuploidy, and morphological grading in selecting embryos of patients with advanced maternal age: a three-armed prospective cohort study. BMC Pregnancy and Childbirth, 24(1), p.545.

15- Ye, C., Duan, H., Liu, M., Liu, J., Xiang, J., Yin, Y., Zhou, Q., Yang, D., Yan, R. and Li, R., 2024. The value of combined detailed first-trimester ultrasound–biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing. Archives of Gynecology and Obstetrics, 310(2), pp.843-853.

Downloads

Published

2025-08-18

How to Cite

Surraya Israr, Hina Akhtar, Zainab Asghar, Muhammad Ahmad Albajuri, Iffat Jabeen, & Mukhzarah Nasr Chaudhry. (2025). ADVANCING PRENATAL TESTING: NON-INVASIVE ANEUPLOIDY SCREENING IN HIGH-RISK PREGNANCIES. Journal of Population Therapeutics and Clinical Pharmacology, 32(7), 624-630. https://doi.org/10.53555/qvnay652
More Citation Formats

Issue

Section

Articles

How to Cite

Surraya Israr, Hina Akhtar, Zainab Asghar, Muhammad Ahmad Albajuri, Iffat Jabeen, & Mukhzarah Nasr Chaudhry. (2025). ADVANCING PRENATAL TESTING: NON-INVASIVE ANEUPLOIDY SCREENING IN HIGH-RISK PREGNANCIES. Journal of Population Therapeutics and Clinical Pharmacology, 32(7), 624-630. https://doi.org/10.53555/qvnay652